Daniil Gataulin

Daniil Gataulin Analyst Performance

Senior Research Analyst, Ophthalmology at Chardan Capital

Daniil Gataulin is a stock analyst at Chardan Capital focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Daniil Gataulin has issued 32 stock ratings, including strong buy, buy, and hold recommendations. While full access to Daniil Gataulin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniil Gataulin's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
136 Last 4 Years
Buy Recommendations
87.41% 118 Buy Ratings
Companies Covered
26 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy86.7%117 ratings
Hold12.6%17 ratings
Sell0.0%0 ratings

Out of 135 total stock ratings issued by Daniil Gataulin at Chardan Capital, the majority (86.7%) have been Buy recommendations, followed by 12.6% Hold and 0.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.2% of companies on NASDAQ
25 companies
NYSE
3.8% of companies on NYSE
1 company

Daniil Gataulin, an analyst at Chardan Capital, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
21 companies
80.8%
Technology
3 companies
11.5%
Industrials
1 company
3.8%
Consumer Discretionary
1 company
3.8%

Daniil Gataulin of Chardan Capital specializes in stock coverage within the Healthcare sector, with additional focus on Technology and Industrials companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
15 companies
57.7%
PHARMACEUTICALS
6 companies
23.1%
SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT
2 companies
7.7%
MACHINERY
1 company
3.8%
SOFTWARE
1 company
3.8%
AUTOMOBILE COMPONENTS
1 company
3.8%

About Daniil Gataulin

Dr. Daniil Gataulin is a Senior Research Analyst at Chardan covering Biotech companies with a focus on ophthalmology. Dr. Daniil Gataulin joined Chardan in the summer of 2021 as a VP, Senior Research Associate covering Biotechnology. Prior to Chardan, he held a Senior Research Associate position at Raymond James, where he covered SMID biotech companies with the focus on neurology, hematology, and gene therapy. Prior to his role at Raymond James, Dr. Gataulin studied the mechanism of DNA repair and recombination in the laboratory of Dr. Doug Bishop at the University of Chicago, where he discovered a novel role for ATP hydrolysis by a DNA repair/recombination protein. Dr. Gataulin holds a BS in Cell Molecular Biology from Grand Valley State University, Master’s degree in Biotechnology from Illinois Institute of Technology, and a PhD in Molecular Genetics and Cell Biology from the University of Chicago.
Follow on LinkedIn

Daniil Gataulin's Ratings History at Chardan Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Laser Photonics Co. stock logo
LASE
Laser Photonics
11/19/2026Initiated Coverage$0.39$2.00Buy
Veritone, Inc. stock logo
VERI
Veritone
11/18/2026Initiated Coverage$0.36$2.00Buy
GCT Semiconductor Holding, Inc. stock logo
GCTS
GCT Semiconductor
11/17/2026Initiated Coverage$1.18$3.00Buy
Worksport Ltd. stock logo
WKSP
Worksport
11/12/2026Initiated Coverage$0.28Buy
Energous Corporation stock logo
WATT
Energous
10/27/2026Initiated Coverage$8.44$15.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
8/3/2026Upgrade$2.81Strong-Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
5/11/2026Upgrade$41.01$61.00Buy
uniQure N.V. stock logo
QURE
uniQure
4/30/2026Boost Price Target$19.95$37.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
3/27/2026Reiterated Rating$1.08$4.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
3/27/2026Reiterated Rating$7.53$35.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/25/2026Reiterated Rating$1.96$7.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
3/23/2026Boost Price Target$5.50$11.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
3/20/2026Reiterated Rating$5.49$16.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
3/18/2026Boost Price Target$4.53$21.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
3/12/2026Boost Price Target$5.01$11.00Buy
uniQure N.V. stock logo
QURE
uniQure
3/9/2026Boost Price Target$17.29$31.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
3/5/2026Reiterated Rating$4.02$15.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/5/2026Reiterated Rating$1.96$7.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3/4/2026Boost Price Target$18.00$29.00Buy
uniQure N.V. stock logo
QURE
uniQure
3/3/2026Lower Price Target$10.50$16.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
2/18/2026Reiterated Rating$0.42Neutral
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
2/18/2026Reiterated Rating$6.99$21.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
2/10/2026Lower Price Target$10.31$50.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
1/29/2026Reiterated Rating$11.01$52.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
1/20/2026Reiterated Rating$1.69$7.00Buy
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
12/23/2025Initiated Coverage$10.06$19.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
12/23/2025Initiated Coverage$5.19$16.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
12/23/2025Initiated Coverage$5.11$16.00Buy
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
12/23/2025Initiated Coverage$9.66$19.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
12/9/2025Reiterated Rating$16.11$21.00Buy
uniQure N.V. stock logo
QURE
uniQure
12/4/2025Reiterated Rating$22.21$53.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
11/20/2025Reiterated Rating$10.93$52.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
11/17/2025Reiterated Rating$14.08$61.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
11/17/2025Reiterated Rating$19.51$14.00Neutral
Zura Bio Limited stock logo
ZURA
Zura Bio
11/14/2025Reiterated Rating$4.08$10.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11/13/2025Reiterated Rating$1.92$9.00Buy
Oculis Holding AG stock logo
OCS
Oculis
11/11/2025Reiterated Rating$19.42$51.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
11/11/2025Reiterated Rating$8.55$35.00Buy
uniQure N.V. stock logo
QURE
uniQure
11/11/2025Reiterated Rating$26.15$53.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11/7/2025Reiterated Rating$1.92$9.00Buy
A $247 tool for $7 (Ad)

Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel

See the Instant Scanner in action and claim the $7 Black Friday deal today.
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
11/5/2025Reiterated Rating$10.90$21.00Buy
uniQure N.V. stock logo
QURE
uniQure
11/3/2025Lower Price Target$34.29$53.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
10/27/2025Downgrade$4.24Hold
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
10/16/2025Initiated Coverage$2.00$9.00Buy
Oculis Holding AG stock logo
OCS
Oculis
10/8/2025Boost Price Target$19.06$51.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
10/6/2025Reiterated Rating$15.45$14.00Neutral
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
10/2/2025Reiterated Rating$11.04$21.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
9/30/2025Reiterated Rating$2.99$10.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/25/2025Boost Price Target$47.50$76.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
9/19/2025Reiterated Rating$1.40$7.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
9/15/2025Initiated Coverage$12.81$21.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/10/2025Downgrade$47.64$48.00Neutral
uniQure N.V. stock logo
QURE
uniQure
9/8/2025Reiterated Rating$17.95$35.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
9/8/2025Reiterated Rating$9.71$52.00Buy
uniQure N.V. stock logo
QURE
uniQure
8/29/2025Reiterated Rating$16.26$35.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
8/28/2025Reiterated Rating$1.09$3.00Neutral
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/15/2025Reiterated Rating$10.82$61.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
8/15/2025Reiterated Rating$1.72$10.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
8/15/2025Reiterated Rating$2.43$3.00Neutral
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
8/15/2025Reiterated Rating$8.33$35.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
8/14/2025Reiterated Rating$21.77$70.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
8/13/2025Reiterated Rating$2.58$33.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
8/11/2025Reiterated Rating$9.85$15.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
8/8/2025Reiterated Rating$7.90$52.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
8/8/2025Reiterated Rating$0.68$4.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
8/7/2025Reiterated Rating$10.58$27.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
8/4/2025Reiterated Rating$0.99$7.00Buy
uniQure N.V. stock logo
QURE
uniQure
7/29/2025Lower Price Target$13.68$35.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
7/18/2025Downgrade$0.60Neutral
Ocugen, Inc. stock logo
OCGN
Ocugen
6/24/2025Reiterated Rating$0.98$7.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
6/24/2025Reiterated Rating$12.76$61.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
6/9/2025Reiterated Rating$9.61$52.00Buy
uniQure N.V. stock logo
QURE
uniQure
5/30/2025Reiterated Rating$14.67$38.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
5/15/2025Reiterated Rating$1.88$33.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
5/14/2025Lower Price Target$5.15$35.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
5/12/2025Reiterated Rating$0.67$7.00Buy
uniQure N.V. stock logo
QURE
uniQure
5/12/2025Reiterated Rating$12.78$38.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
5/12/2025Boost Price Target$9.10$15.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/9/2025Boost Price Target$18.70$33.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
5/8/2025Lower Price Target$0.35$4.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5/8/2025Lower Price Target$6.09$27.00Buy
uniQure N.V. stock logo
QURE
uniQure
5/6/2025Reiterated Rating$15.89$38.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
5/5/2025Reiterated Rating$16.30$70.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
4/23/2025Initiated Coverage$17.32$70.00Buy
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
4/23/2025Reiterated Rating$0.98$4.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
4/17/2025Lower Price Target$2.98$33.00Buy
Oculis Holding AG stock logo
OCS
Oculis
4/17/2025Reiterated Rating$18.02$28.00Buy
uniQure N.V. stock logo
QURE
uniQure
4/1/2025Initiated Coverage$10.60$38.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
4/1/2025Lower Price Target$7.43$61.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
3/28/2025Reiterated Rating$15.45$90.00Buy
A $247 tool for $7 (Ad)

Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel

See the Instant Scanner in action and claim the $7 Black Friday deal today.
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
3/25/2025Lower Price Target$1.30$4.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
3/21/2025Lower Price Target$0.43$8.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
3/20/2025Reiterated Rating$8.50$52.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
3/14/2025Reiterated Rating$6.55$52.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
3/13/2025Upgrade$6.17$14.00Buy
Oculis Holding AG stock logo
OCS
Oculis
3/13/2025Reiterated Rating$18.84$28.00Buy
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
3/10/2025Reiterated Rating$1.68$6.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/6/2025Boost Price Target$0.57$7.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3/6/2025Reiterated Rating$6.82$33.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
2/26/2025Reiterated Rating$0.50$11.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
2/24/2025Reiterated Rating$7.30$36.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
2/18/2025Reiterated Rating$1.87$3.00Neutral
Ocugen, Inc. stock logo
OCGN
Ocugen
2/13/2025Reiterated Rating$0.66$6.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2/6/2025Reiterated Rating$7.80$33.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
1/23/2025Reiterated Rating$0.75$6.00Buy
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
1/10/2025Initiated Coverage$1.33$6.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
12/11/2024Reiterated Rating$2.16Neutral
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
12/2/2024Reiterated Rating$2.05Neutral